| Q36223710 | Advances in understanding immunologic control of HIV infection |
| Q35923352 | Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals |
| Q37014116 | Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials |
| Q61835542 | CIVD, choc septique : Diagnostic biologique et traitements innovants |
| Q35784804 | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load |
| Q37789343 | Clinical management of acute HIV infection: best practice remains unknown |
| Q28111910 | Depletion of latent HIV-1 infection in vivo: a proof-of-concept study |
| Q36474240 | Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 |
| Q39683633 | Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication |
| Q37083535 | Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load |
| Q75291760 | Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients |
| Q37118025 | Factors associated with 10 years of continuous viral load suppression on HAART. |
| Q81635076 | Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among HIV-1 infected individuals before and after antiretroviral therapy |
| Q33950164 | High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation |
| Q37596842 | Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels |
| Q33839448 | Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. |
| Q35023525 | Immune intervention strategies for HIV-1 infection of humans in the SIV macaque model. |
| Q34876070 | Immune reconstitution |
| Q35923609 | Immunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapy |
| Q37243692 | Immunophenotypic alterations in acute and early HIV infection |
| Q40266788 | Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1. |
| Q36670882 | Innate immune defenses in HIV-1 infection: prospects for a novel immune therapy |
| Q33593588 | Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir |
| Q43967318 | Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects |
| Q34604834 | Plasticity of lymphoid compartments during HIV infection and treatments: hopes and limits |
| Q53885344 | Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort. |
| Q34332703 | Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy |
| Q45723089 | Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| Q36052251 | Slow resolution of inflammation in severe adult dengue patients |
| Q34207580 | Structured treatment interruptions to control HIV-1 and limit drug exposure |
| Q34642229 | The Role of Antigen-presenting Cells in HIV Pathogenesis |
| Q74780517 | The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection |
| Q44734008 | Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well tolerated |
| Q27346577 | Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques |
| Q49212979 | Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells |
| Q37393518 | Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells |